Medicine and Dentistry
Hypoxia
100%
Apoplexy
100%
Patient
86%
Cells
75%
SH-SY5Y
75%
Brain Ischemia
73%
Therapeutic Procedure
62%
Percutaneous Thrombectomy
61%
Health Care Cost
55%
In Vitro
50%
Ischemia
50%
Etiology
50%
Association
50%
Thrombus
50%
Differentiation
50%
Perfusion
50%
Health
50%
Posterior Cerebral Artery
50%
Occlusive Cerebrovascular Disease
50%
Platelet
27%
Erythrocyte
27%
Fibrin
27%
Programmed Cell Death
25%
Inflammation
25%
Oxidative Stress
25%
Induced Pluripotent Stem Cell
23%
Microelectrode
18%
Brain Disease
16%
Quality Adjusted Life Year
13%
Neuroprotective Agent
12%
Species
12%
Stimulation
12%
Cell Line
12%
Modified Rankin Scale
10%
Symptom
9%
Patient Selection
9%
Monitoring
5%
Leukocyte
5%
Cardiac Dysrhythmia
5%
Treatment Classification
5%
Learning
5%
Inpatient
5%
Leukocyte
5%
Analysis
5%
Morphology
5%
Base
5%
Metabolic Stress
5%
Microtubule Associated Protein 2
5%
Glass
5%
Neuroscience
Neuron
100%
In Vitro
100%
Stroke
83%
Neuroprotective Agent
62%
Ischemia
50%
Brain
50%
Brain Ischemia
50%
N-Methyl-D-Aspartic Acid
50%
Neurological Disorder
50%
Stem Cell
50%
Enhancer Region
50%
Hypothermia
50%
Ischemic Stroke
41%
Oxidative Stress
25%
Cell Line
12%
Neuroblastoma
12%
Microtubule Associated Protein 2
8%
Immunocytochemistry
5%
Pharmacology, Toxicology and Pharmaceutical Science
Etiology
50%
Ischemia
50%
Thrombus
50%
Fibrinolytic Agent
50%
Hypoxia
50%
Brain Ischemia
50%
Brain Ischemia
36%
Fibrin
27%
Cell Death
25%
Inflammation
25%
Neuroblastoma
12%
Neuroprotective Agent
12%
Rankin Scale
12%
Experimental Animal
12%
Normal Human
12%
Rankin Scale
10%
Heart Arrhythmia
5%
Cerebrovascular Accident
5%
Occlusion
5%